REDUCEDStaleAutolus Therapeutics Ltd · NASDAQ−6,713 sh · $15.7KFiled 3 Sept 2026·SEC Form 4·view source
ACQUIREDStaleAutolus Therapeutics Ltd · NASDAQ+20,000 sh · $47.0KFiled 3 Sept 2026·SEC Form 4·view source